Apollo Hospitals Enterprise (APOLLOHOSP) Fundamentals 2026 — P/E 66.2x, Revenue Analysis | SniperIQ
Apollo Hospitals Enterprise (APOLLOHOSP) is a India-listed Healthcare company in Medical - Care Facilities with a market capitalization of ₹1.28 Lakh Crore, trading at ₹8938.10 on the BSE. This SniperIQ fundamentals page covers Apollo Hospitals Enterprise's valuation (P/E 66.2x, P/B 13.6x), profitability (net margin 7.7%), revenue (₹25,229 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Apollo Hospitals Enterprise's market cap?
Apollo Hospitals Enterprise (APOLLOHOSP) has a market capitalization of approximately ₹1.28 Lakh Crore, trading at ₹8938.10 on the BSE. Market cap moves with the live share price.
What is Apollo Hospitals Enterprise's P/E ratio?
Apollo Hospitals Enterprise's trailing twelve-month P/E ratio is 66.2x, with a price-to-book (P/B) of 13.6x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Apollo Hospitals Enterprise?
Apollo Hospitals Enterprise runs a net profit margin of 7.7%, a gross margin of 37.5%, and an operating margin of 17.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Apollo Hospitals Enterprise generate?
Apollo Hospitals Enterprise reported revenue of ₹25,229 Crore for fiscal year 2026, with net income of ₹1,942 Crore and earnings per share (EPS) of 135.04. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Apollo Hospitals Enterprise pay a dividend?
Apollo Hospitals Enterprise offers a trailing dividend yield of about 0.2%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Apollo Hospitals Enterprise financially healthy?
Apollo Hospitals Enterprise carries a debt-to-equity ratio of 0.90x and a current ratio of 1.06x, with a market beta of 0.18. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Apollo Hospitals Enterprise a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Apollo Hospitals Enterprise (APOLLOHOSP) the key facts are: market cap ₹1.28 Lakh Crore, P/E 66.2x, revenue ₹25,229 Crore, 52-week range 6680-9008.9. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Apollo Hospitals Enterprise's full fundamentals live
Get Apollo Hospitals Enterprise's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.